IWTNF yields 2.63% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, IWTNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IWTNF + PFE for your $10,000?
Iwatani Corporation supplies gases and energy in Japan, China, Taiwan, South Korea, Singapore, Thailand, Malaysia, Indonesia, Vietnam, the United States, and Australia. It operates through four segments: Energy, Industrial Gases & Machinery, Materials, and Agri-Bio & Foods. The Energy segment offers LPG for household, commercial, and industrial use; LPG-supply equipment and facilities; LNG; petroleum products; household kitchen appliances; and home energy components, Ene farm, GHP, daily necessities, portable cooking stoves, gas canisters, mineral water, health foods, electricity, etc. The Industrial Gases & Machinery segment provides air separation gases, hydrogen, helium, other specialty gases, gas supply facilities, welding materials, welding and cutting equipment, industrial robots, pumps and compressors, disaster prevention equipment, and high-pressure gas containers; and semiconductor manufacturing equipment, electronic component manufacturing equipment, factory automation systems, medicine and food packing machinery, environmental equipment, etc., as well as operates facilities for hydrogen stations. The Materials segment provides PET and general-purpose resins, biomass fuels, secondary battery and semiconductor materials, electronic display films, mineral sand, rare earth, ceramics materials, stainless steels, aluminum, etc. The Agri-bio & Foods segment offers frozen and chilled foods, agricultural equipment and materials, livestock related goods, etc. The company was founded in 1930 and is headquartered in Osaka, Japan.
Full IWTNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.